Researchers and the Israeli company MeMed are transforming the way coronavirus is treated. Doctors are using technology that decodes patients’ immune system response against coronavirus in order to personalize treatment for each patient. FOX’s Trey Yingst speaks with Eran Eden, the CEO of MeMed, on how this technology is helping doctors predict the severity of the coronavirus and other diseases in patients.

Learn more about your ad choices. Visit podcastchoices.com/adchoices